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Abstract
The Neurofascins (NFASCs) are a family of proteins encoded by alternative transcripts of NFASC that cooperate in the
assembly of the node of Ranvier in myelinated nerves. Differential expression of NFASC in neurons and glia presents a
remarkable example of cell-type specific expression of protein isoforms with a common overall function. In mice there are
three NFASC isoforms: Nfasc186 and Nfasc140, located in the axonal membrane at the node of Ranvier, and Nfasc155, a glial
component of the paranodal axoglial junction. Nfasc186 and Nfasc155 are the major isoforms at mature nodes and
paranodes, respectively. Conditional deletion of the glial isoform Nfasc155 in mice causes severe motor coordination
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defects and death at 16–17 days after birth. We describe a proband with severe congenital hypotonia, contractures of fingers
and toes, and no reaction to touch or pain. Whole exome sequencing revealed a homozygous NFASC variant
chr1:204953187-C>T (rs755160624). The variant creates a premature stop codon in 3 out of four NFASC human transcripts
and is predicted to specifically eliminate Nfasc155 leaving neuronal Neurofascin intact. The selective absence of Nfasc155
and disruption of the paranodal junction was confirmed by an immunofluorescent study of skin biopsies from the patient
versus control. We propose that the disease in our proband is the first reported example of genetic deficiency of glial
Neurofascin isoforms in humans and that the severity of the condition reflects the importance of the Nfasc155 in forming
paranodal axoglial junctions and in determining the structure and function of the node of Ranvier.
Introduction
Neurofascin (NFASC) proteins are encoded by NFASC. They are
members of the L1 family of immunoglobulin cell adhesion
molecules and play a critical role in the assembly of the node of
Ranvier, the axonal domain in myelinated nerves that is respon-
sible for rapid nerve impulse conduction in the vertebrate central
and peripheral nervous systems (CNS and PNS) (1–3). In mice
there are three Neurofascin proteins however, Nfasc186 and
Nfasc155 are the major isoforms responsible for node assembly
(4–6).
Nfasc186 is located in the axonal membrane at the node
of Ranvier in myelinated vertebrate nerves whereas Nfasc155
is a glial component of the paranodal axoglial junction that
flanks the node (2,6). Nfasc155 is expressed by myelin-forming
oligodendrocytes in the CNS and Schwann cells in the PNS.
Both Neurofascin isoforms have each been shown to play crucial
roles in the clustering of voltage-gated sodium (Nav) channels
at the node of Ranvier (1–3). Although Nfasc186 is not essen-
tial for the clustering of Nav channels at the unmyelinated
proximal domain of axons, the Axon Initial Segment (AIS), it
is required for the long-term maintenance and stability of the
AIS (7).
Interestingly, the clustering of Nav at the node of Ranvier
can be accomplished either by Nfasc186, or by the formation
of a paranodal junction by oligodendrocyte Nfasc155 with its
axonal binding partners Caspr and Contactin (3,6). Nevertheless,
even when Nfasc186 is present, mice specifically lacking the
glial isoform Nfasc155 show severe motor coordination defects
and die prematurely at 16–17 days after birth (8). Furthermore,
specific loss of Nfasc155 has been shown to disrupt synapse
elimination at the developing neuromuscular junction (9). This
is surprising since disruption of the paranodal axoglial com-
plex through the loss of Caspr is much less severe and mice
live beyond 5 months (10). Taken together, these data from
mouse studies show that loss of Nfasc155 has a severe phe-
notype beyond the simple disruption of the paranodal axoglial
junction.
Recently, it has been reported that patients with chronic
inflammatory demyelinating polyneuropathy possess anti-
Nfasc155 immunoglobulin antibodies (11). Further, it has been
proposed that a T-helper1 response against Nfasc186 may be
used as a biomarker for multifocal acquired demyelinating
sensory and motor polyneuropathy (12). However, thus far
mutations in the NFASC gene as a cause of a human mendelian
disorder have not been described.
In the present study we describe a proband with a novel
homozygous NFASC mutation that is predicted to selectively
affect Nfasc155 leaving the neuronal isoforms intact. We confirm
the selective absence of oligodendrocyte Nfasc155 and disrup-
tion of the ternary complex at the paranodal junction. Moreover,
and consistent with previous studies on mice, loss of Nfasc155
leads to a severe clinical phenotype.
Results
Bioinformatics analysis of whole exome sequencing (WES)
data revealed a homozygous variant chr1:204953187-C>T
(rs755160624) in the NFASC gene (Fig. 1). rs755160624 is predicted
to create a premature stop codon in three out of the following
four NFASC transcripts: NM_015090.3, c.2491C>T, (p.Arg831Ter),
exon 21 of 27, amino acid (aa) 831 of 1170; NM_001160331.1,
c.2536C>T, (p.Arg846Ter), exon 20 of 27, aa 846 of 1190 and
NM_001160332.1, c.2491C>T, (p.Arg831Ter), exon 21 of 28, aa
831 of 1175 (RefSeq Transcripts Version: 27-Feb-2018). In the
remaining NFASC transcript NM_001005388.2 the variant is
predicted to affect a noncoding position located deeply within
intron 21 (intronic position 2039 of 5397, c.2470 + 2039C>T).
NM_001005388.2 is the canonical NFASC transcript encoding the
longest protein isoform of 1241 aa corresponding to Nfasc186 (5).
Thus, homozygosity for rs755160624 is predicted to cause loss
of shorter noncanonical NFASC isoforms including the human
counterpart of glial Nfasc155 (NM_001160331.1), while leaving
the longest (neuronal) isoform intact (5) (Fig. 2). A family study
using amplicon deep sequencing (ADS) and Sanger sequencing
confirmed the homozygosity for rs755160624 in the proband and
showed the heterozygous carrier status of her healthy parents
(Fig. 1).
rs755160624 has been previously reported in four het-
erozygous subjects from the GnomAD database three of
whom were from a European population and one from a
Finnish population (European population frequency of 1
in 21114 subjects, http://gnomad.broadinstitute.org/). The
rs755160624 was not found in an in-house database of >1000
Polish exomes.
Given the low population frequency of rs755160624 we reex-
amined the issue of the relatedness of proband’s parents. When
interviewed again the parents confirmed lack of consanguinity
but reported that the paternal grandmother of the proband’s
mother was born in the same small village in Ukraine as the
grandparents of the proband’s father. We also analyzed the WES
data for runs of homozygosity (ROHs). In the proband we found
four ROHs ranging from 5.37–2.65 Mb with a total length of
13.83 Mb. rs755160624 was located within one of the detected
ROHs with a length of 3.04 Mb. Analysis of ROHs in 324 samples
from unrelated subjects from a Polish population in which WES
was performed with the same protocol as in the proband’s
showed that in 28 (9%) of samples the summed ROH length was
longer or equal than in proband.
Immunofluorescence studies
In order to confirm the predicted lack of Nfasc155 in nerves
we evaluated peripheral myelinated axons in skin biopsies
from the proband and control. Nfasc155 was absent at the
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Figure 1. Results of genetic analyses of rs755160624 (NM_015090.3 c.2491C>T, (p.Arg831Ter) in the NFASC gene. (A) WES in proband (IGV view), (B–D) results of Sanger
sequencing and ADS confirming the homozygosity of proband (B total count 11436, C-143 (1%), T-11207 (98%)), and demonstrating heterozygosity of her mother (C total
count 9774, C-4823 (49%), T-4902 (50%)) and father (D total count 12620, C-6317 (50), T-6245 (49%)).
Figure 2. Schematic view of the domain structure of neuronal and glial human Neurofascin isoforms, Nfasc186 (NM_001005388.2) and Nfasc155 (NM_001160331.1),
showing the exons that encode the five Fibronectin Type III (FNIII) repeats. The homozygous rs755160624 variant found in the proband creates a stop codon in the third
FNIII repeat specific to the glial Nfasc155 isoform.
biopsies from control and proband glabrous skin were stained by
immunofluorescence to reveal myelinated axons using antibod-
ies against both myelin basic protein (MBP) and neurofilament
H (NF-H). The presence of both neuronal Neurofascin at the
node and glial Nfasc155 at the paranodal axoglial junction in
the control was revealed by staining with a pan-Nfasc antibody.
However, only the nodal isoforms were present in proband nerve
fibres while the glial paranodal Nfasc155 was missing (Fig. 3).
Furthermore, an antibody that is specific for glial Nfasc155
immunostained the paranodes of control but not proband nerve
fibres, confirming the absence of this Neurofascin isoform in
the proband. Axonal Caspr and Contactin and glial Nfasc155
together form the ternary axoglial junctional complex at the
paranode (Fig. 3). Hence, the loss of Caspr at the paranodes in
the proband confirmed the disruption of the axoglial complex
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Figure 3. Nfasc155 is absent at the paranode of peripheral myelinated axons. Sections (5 mm thick) of biopsies from control and proband glabrous skin from infants of
11 and 2 months of age, respectively, were stained by immunofluorescence to reveal myelinated axons using antibodies against both MBP and NF-H. (A) The presence of
both nodal neuronal NFASC isoforms (Nfasc186 and Nfasc140) at the node and glial Nfasc155 at the paranodal axoglial junction is revealed by staining with a pan-Nfasc
antibody in the control. However, only the nodal isoforms are present in proband nerve fibres. The glial paranodal Nfasc155 is missing. (B) An antibody specific for glial
Nfasc155 immunostains the paranodes of control but not proband nerve fibres, confirming the absence of this NFASC isoform in the proband. (C) Caspr is an axonal
component of the paranodal axoglial complex with glial Nfasc155. Loss of Caspr at the paranodes in the proband confirms that the paranodal junction is disrupted due
to the loss of Nfasc155. The arrowheads point to the location of paranodes and the arrows point to nodes. Size marker, 5 mm.
Discussion
We found a recessive, homozygous NFASC variant rs755160624
in the proband which is associated with severe and progressive
neurological disease. rs755160624 NFASC variant is located in
the third FNIII repeat specific for the glial NFASC155 isoform
(Fig. 2). In the homozygous state this NFASC variant is thus
predicted to cause selective loss of the glial-specific Nfasc155
isoform whereas Nfasc186, the major neuronal isoform at the
node of Ranvier, should not be affected. This prediction was
substantiated by an immunofluorescence study using a pan
reactive Nfasc antibody which demonstrated the lack of glial
paranodal Nfasc155 in the proband, whereas neuronal NFASC
was present. Furthermore, Caspr was absent from the paran-
odes of the proband confirming the disruption of the paranodal
junction.
On clinical grounds proximal spinal muscular atrophy (SMA)
was initially suspected in our proband. Symptoms supporting
the SMA diagnosis included weak fetal movements, polyhy-
dramnios, severe hypotonia, congenital contractures and pri-
mary respiratory distress. However, a lack of response to light
and epilepsy indicating involvement of the CNS was not typical
for SMA and we suggest that these symptoms could be useful for
clinical differentiation between SMA and the NFASC associated
disease.
The loss of nociceptive responses may reflect deficiencies in
both the CNS and PNS. Myelinated A delta nerve fibers respon-
sive to mechanical and painful stimuli normally have much
slower conduction velocities than A beta fibers in peripheral
nerves. From our mouse work we would predict a further 50%
reduction in conduction velocities in these peripheral nerves as
a result of the loss of intact paranodal axoglial junctions due to
the absence of Nfasc155 (9). This would seem likely to contribute
to decreased responses to mechanical and painful stimuli in
the patient, although we cannot preclude the effect of reduced
conduction velocities in the CNS as a further contributory factor.
Mice lacking all NFASC isoforms die at post-natal day 7 (P7)
(1). NFASC-null mice that over-express either of the two neuronal
isoforms (Nfasc186 or Nfasc140) survive into adulthood but are
ataxic, presumably because they do not have intact paranodal
axoglial junctions (no Nfasc155) in their myelinated nerves (2).
These mice have conduction velocities in their peripheral nerves
that are 50% of normal. However, selective deletion of glial
Nfasc155 in the presence of normal levels of neuronal NFASC
causes a very severe phenotype in mice resulting in early post-
natal death (8,9). Clearly, over-expression of nodal NFASC can
compensate for the disruption of the paranodal axoglial junction
to a significant degree. However, why the absence of Nfasc155
should cause a much more severe phenotype in mice than loss
of Caspr is still not understood. Nevertheless, the phenotype of
our proband reflects the severity of the murine phenotype and
confirms that the paranodal, glial isoform of NFASC, Nfasc155,
has a particularly important role in nodal function.
Homozygosity for an extremely rare variant in a Polish
population such as rs755160624 in a child of a reportedly non-
consanguineous couple is unusual and raises the possibility
of an unknown/undisclosed relatedness. The finding that
rs755160624 was within a relatively long (>3 Mb) ROH together
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in the proband’s exome as well as the information that three
of her grand-grand-parents were born in the same village all
indicate that a low but distinct degree of parental consanguinity
contributed to the proband’s rs755160624 homozygosity.
In conclusion, we provide the first description of the proband




The proband was the first child of a healthy non-consanguineous
Polish couple. The family history was noncontributory. The
girl was born at 34 weeks of gestation by cesarean section.
The pregnancy was affected by polyhydramnios and weak
fetal movements. Hence, prenatally, fetal esophageal atresia
was suspected. The birth parameters were the following:
weight 2180 g (10–50 percentile), occipitofrontal circumference
31 cm (50 percentile), Apgar score 1/2/4/4 points in 1, 3, 5 and
10 min. The newborn was treated by intubation and mechanical
ventilation because of respiratory insufficiency. The newborn
presented no muscle tension and reflexes. No congenital defects
were noted. Ultrasound examination showed normal heart
structure. Physical examination revealed severe hypotonia
and contractures of finger in hands and feet. Neurological
consultation at 5 days of life showed no reaction to touch
or pain, narrow, symmetric pupils, no response to light and
tongue in midsaggital location, no fasciculations. Amimia,
muscular hypotonia and areflexia were noted as well as motor
and oral automatisms were absent. Head circumference was
32 cm, anterior fontanelle 2x2 cm at the skull level. Brain and
cervical spine magnetic resonance imaging did not reveal any
pathology apart from discrete ischemic and hypoxic changes.
Electroencephalography showed unspecific changes. Tandem
mass spectrometry, gas chromatography–mass spectrometry
assays and aminoacids profile in serum and cerebro-spinal
fluid revealed no abnormalities; lactic acid, CPK and NH3 levels
were in the normal range. Levels of C and S proteins and the
level of immunoglobulin were in normal range. Ophthalmology
examination did not show any abnormalities.
SMN1 and SMN2 genetic tests (MLPA 060-B2 SMA) were per-
formed and yielded normal results (no deletion of exon 7 and
8 in the SMN1 gene and deletion of one allele of SMN2 gene).
Because of feeding difficulties percutaneous endoscopic gastros-
tomy was performed. Subsequent neurological consultation at
12 weeks showed vestigial spontaneous motorics (weak move-
ment of upper and lower limbs), amimia, no eye contact, hypo-
tonia, symmetric, extensor dominance, areflexia and absence of
motor and oral automatism. Chronic respiratory insufficiency
and severe neurological status without improvement prompted
tracheostomy. At the age of 3 months, the infant was admitted to
a palliative care unit. Severe hypotonia was observed with very
low touch reaction, without sucking reflex, without eye contact.
At the age of 4 months epilepsy appeared and was treated with
valproate.
Genetic study
Venous blood samples were collected from all participants of
the study (proband and parents). Written informed consent was
obtained prior to genetic testing from the parents (the legal
guardians of the proband). Ethics approval was granted by the
Institutional Review Board of Warsaw Medical University.
WES was performed on the proband using SureSelect Human
All Exon V5 (Agilent Technologies, Palo Alto, CA) on HiSeq 1500
(Illumina, San Diego, CA). Bioinformatics analysis of WES data
was performed using a previously described pipeline (13). The
mean depth of coverage in the sequenced sample was 78x, 91% of
target sequence was covered min 20x and 97% min 10x. In order
to confirm the results from WES and to verify the carrier state of
the participants of the study ADS was performed using Nextera
XT Library Preparation Kit (Illumina, San Diego, CA). Sequencing
was carried out on HiSeq 1500. The following PCR primers were
used for ADS: NFASC_F - 5′AGT GTT GAG TGG AGT GCA GGT 3′,
NFASC_R – 5′ TCT TAT AGC CCG CAT TTG CT 3′. The same primers
were used for Sanger sequencing.
ROHs were detected using the bcftools program (14) with
variants detected by the GATK HaplotypeCaller algorithm (15)
as input. Variants were called only within the target enrichment
region. GnomAD database (16) was used as the source of refer-
ence allele frequencies and genetic maps were taken from the
1000 Genomes project (17).
Immunofluorescence study
Skin biopsies in the proband were obtained from the glabrous
skin of a first toe using a 2 mm punch and were fixed in cold
Zamboni’s fixative for 4–5 h, followed by washes with 100 mM
Sorenson’s phosphate buffer (pH 7.4). The control biopsy was
obtained from the glabrous skin of a supernumerary toe of an 11-
month-old infant who underwent surgery for polydactyly. The
tissue was cryoprotected with 25% sucrose in 100 mM Sorenson’s
phosphate buffer and frozen in OCT (CellPath). Sections (5 um)
were cut on a cryostat (Leica) and collected on Superfrost Plus
slides. Sections were blocked with 5% fish skin gelatin (Sigma),
0.2% Triton-X100 in Phosphate-buffered saline (PBS) for one
hour, followed by incubation in primary antibodies overnight at
room temperature. After PBS washes sections were incubated
for 1.5 h with secondary antibodies. Primary antibodies were
used at the following dilutions: rabbit Pan Nfasc (NFC1) 1:2000
(6), rabbit Nfasc155 (NFF3) 1:1000 (6), rabbit Caspr 1:5000 (gift of
Dr. D.R. Colman), rat MBP 1:200 (AbD Serotec) and Neurofilament-
200 (Sigma) 1:1000. Secondary antibodies (Invitrogen Molecu-
lar Probes) were used at 1:1000 dilution and were goat anti-
rabbit IgG AlexaFluor 488, goat anti-rat IgG AlexaFluor 594 and
goat anti-mouse IgG1 AlexaFluor 647. Sections were mounted
in Vectashield (Vector Laboratories). Confocal microscopy was
performed using a Leica TCL-SL microscope with a 63x objective
(1.4 NA).
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